Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study

References

• Moyer VA, U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:349–357.
   PubMed Web of Science ®Google Scholar
• Burns DN, Minkoff H. Hepatitis C: screening in pregnancy. Obstet Gynecol. 1999;94:1044–1048.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy. ACOG Practice Bulletin no. 86. Obstet Gynecol. 2007;110:941–955.
   PubMedGoogle Scholar
• Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59:1411–1419.
   PubMed Web of Science ®Google Scholar
• Salihu HM, Connell L, Salemi JL, August EM, Weldeselasse HE, Alio AP. Prevalence and temporal trends of hepatitis B, hepatitis C, and HIV/AIDS co-infection during pregnancy across the decade, 1998–2007. J Womens Health. 2012;21:66–72.
   PubMed Web of Science ®Google Scholar
• Berkley EMF, Leslie KK, Arora S, Qualls C, Dunkelberg JC. Chronic hepatitis C in pregnancy. Obstet Gynecol. 2008;112:304–310.
   PubMed Web of Science ®Google Scholar
• Cottrell EB, Chou R, Wasson N, Rahman B, Guise JM. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158:109–113.
   PubMed Web of Science ®Google Scholar
• Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse. 1999;34:1137–1165.
   PubMed Web of Science ®Google Scholar
• Hallinan R, Byrne A, Amin J, Dore GJ. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. J Gastroenterol Hepatol. 2005;20:1082–1086.
   PubMed Web of Science ®Google Scholar
• Spencer JD, Latt N, Beeby PJ, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepatitis. 1997;4:395–409.
   PubMed Web of Science ®Google Scholar
• Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period—are they opportunities for treatment? J Viral Hepatitis. 2011;18:229–236.
   PubMed Web of Science ®Google Scholar
• Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology. 2000;31:751–755.
   PubMed Web of Science ®Google Scholar
• Olsen A, Temple-Smith M, Banwell C. Consideration of gender in diagnosis and management of blood-borne viruses: the case of hepatitis C. Aust J Primary Health. 2013;19:124–129.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Opioid abuse, dependence, and addiction in pregnancy. Committee Opinion No. 524. Obstet Gynecol. 2012;119:1070–1076.
   PubMedGoogle Scholar
• Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
   Google Scholar
• Box GEP, Draper NR. Empirical Model-Building and Response Surfaces. New York: John Wiley & Sons; 1987.
   Google Scholar
• Steyerberg EW. Clinical Prediction Models. New York: Springer; 2009.
   Google Scholar
• Liu AJW, An EI, Murray HG, Tetstall E, Leroi MJ, Nanan RKH. Screening for hepatitis C virus infection in methadone-maintained mothers and their infants. Med J Aust. 2009;191:535–538.
   PubMed Web of Science ®Google Scholar
• Schauberger CW, Newbury EJ, Colburn JM, Al-Hamadani M. Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting. Am J Obstet Gynecol. 2014;211:255.e1–4.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47:1–39.
   PubMedGoogle Scholar
• McNicholas LF, Holbrook AM, O'Grady KE, et al. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction. 2012;107(Suppl 1):91–97.
   PubMed Web of Science ®Google Scholar
• Zickmund SL, Brown KE, Bielefeldt K. A systematic review of provider knowledge of hepatitis C: Is it enough for a complex disease? Digest Dis Sci. 2007;52:2550–2556.
   PubMed Web of Science ®Google Scholar
• Jones L, Atkinson A, Bates G, et al. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research. Int J Drug Policy. 2014;25:204–211.
   PubMed Web of Science ®Google Scholar
• North CS, Devereaux R, Pollio DE, Hong BA, Jain MK. Patient perspectives on hepatitis C and its treatment. Eur J Gastroenterol Hepatol. 2014;26:74–81.
   PubMed Web of Science ®Google Scholar
• Jordan AE, Masson CL, Mateu-Gelabert P, et al. Perceptions of drug users regarding hepatitis C screening and care: A qualitative study. Harm Reduct J. 2013;10:10.
   PubMed Web of Science ®Google Scholar
• Zickmund SL, Campbell SA, Tirado CF, Zook CL, Weinrieb RM. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment. J Addict Med. 2012;6:233–239.
   PubMed Web of Science ®Google Scholar
• Chen EY, North CS, Fatunde O, et al. Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults. J Viral Hepatitis. 2013;20:708–714.
   PubMed Web of Science ®Google Scholar
• Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis C screening among people who inject drugs: A multi-city, mixed-methods study. Harm Reduct J. 2014;11:1.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–826.
   PubMed Web of Science ®Google Scholar
• Terplan M, Smith EJ, Glavin SH. Trends in injection drug use among pregnant women admitted into drug treatment: 1994–2006. J Womens Health. 2010;19:499–505.
   Web of Science ®Google Scholar